IFF - International Flavors & Fragrances Inc Stock Analysis

International Flavors & Fragrances Inc (IFF) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 21.85B, generates annual revenue of 9.98B, and reports net income of 277.00M. As of the latest data, the stock is trading at 85.62 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (1.91%), which may appeal to income-focused investors. The stock has average market volatility, aligning with general market movement.

Analyst recommendation stands at Buy (4.0), indicating current market sentiment. Institutional ownership is reported at 107.58%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 29.39%, trading within a 52-week range of 59.14 - 89.32.

IFF - International Flavors & Fragrances Inc

85.62
Analyst Consensus
Buy 4.0
IFF – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 7
  • Buy: 11
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0
  • Total Analysts:  25

Last update: 2026-09-09 04:28:43
Index: S&P 500 P/E: 79.44 EPS (ttm): 1.08 Insider Own: 1.83% Shs Outstand: 255.30M Perf Week: -0.82%
Market Cap: 21.85B Forward P/E: 21.49 EPS next Y: 3.98 Insider Trans: 10.10% Shs Float: 250.47M Perf Month: -0.31%
Income(ttm): 277.00M PEG: 7.99 EPS next Q: 0.80 Inst Own: 107.58% Short Float: 6.13% Perf Quarter: 17.93%
Revenue(ttm): 9.98B P/S: 2.19 EPS this Y: -18.43% Inst Trans: 5.42% Short Ratio: 8.71 Perf Half Y: 17.03%
Book/sh: 54.74 P/B: 1.56 EPS next Y: 16.31% ROA: 1.01% Short Interest: 15.36M Perf Year: 29.39%
Cash/sh: 2.23 P/C: 38.39 EPS next 5Y: 2.69% ROE: 1.83% 52W Range: 59.14 - 89.32 Perf YTD: 27.05%
Dividend Est.: 1.64 (1.91%) P/FCF: 40.61 EPS past 3/5Y: 42.26% - ROIC: 1.44% 52W High: 89.32 -4.14% Beta: 0.93
Dividend TTM: 1.60 (1.87%) Quick Ratio: 1.71 Sales past 3/5Y: -4.34% 16.46% Gross Margin: 32.44% 52W Low: 59.14 44.78% Perf 5Y: -43.31%
Dividend Ex-Date: Sep 18, 2026 Current Ratio: 2.06 EPS Y/Y TTM: 170.53% Oper. Margin: 10.48% RSI (14): 54.85 Volatility: 1.82% 2.05%
Employees: 21500 Debt/Eq: 0.45 Sales Y/Y TTM: -11.72% Profit Margin: 2.78% Recom: 1.73 Target Price: 95.69
Option/Short: Yes / Yes LT Debt/Eq: 0.37 EPS Q/Q: -91.83% Payout: - Rel Volume: 0.95 Prev Close: 86.35
Sales Surprise: -25.45% EPS Surprise: -23.03% Sales Q/Q: -29.31% Earnings: Aug 04 AMC Avg Volume: 1.76M Price: 85.62
SMA20: 0.53% SMA50: 4.82% SMA200: 14.55% Undervalued: 11.76%
Volume: 1,678,658 Change: -0.85%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About International Flavors & Fragrances Inc

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.